Evommune Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Evommune stock have an average target of 39.33, with a low estimate of 36 and a high estimate of 42. The average target predicts an increase of 79.59% from the current stock price of 21.90.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$36	$39.33	$40	$42
Change	+64.38%	+79.59%	+82.65%	+91.78%

Analyst Ratings

The average analyst rating for Evommune stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25
Strong Buy	0
Buy	5
Hold	0
Sell	0
Strong Sell	0
Total	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Phipps William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 1, 2025
Prakhar Agrawal Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 1, 2025
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $36	Buy	Initiates	$36	+64.38%	Dec 1, 2025
Thomas Smith Leerink Partners	Leerink Partners	Buy Initiates $42	Buy	Initiates	$42	+91.78%	Dec 1, 2025
Gavin Clark-Gartner Evercore ISI Group	Evercore ISI Group	Buy Initiates $40	Buy	Initiates	$40	+82.65%	Dec 1, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.